Jun 2, 2021|

JD and Pfizer China Launch Children’s Vaccination Health-Management Program


by Hui Zhang

JD Health and Pfizer China announced plans to initiate a health-management program for children’s vaccinations on May 28 in Beijing, aiming to provide a one-stop service covering vaccination-related knowledge sharing, appointments, online consultations, and other follow-up services. The program will mainly focus on vaccinations against pneumococcal disease at the first stage.

The program is a further step since both sides agreed to expand cooperation at the 3rd China International Import Expo (CIIE) in 2020. The World Health Organization (WHO) has classified pneumococcal disease in children as a disease “requiring very high priority” for vaccine prevention.

In response to the current difficulties in vaccination education, non-transparent information about reservations, and queues at some medical institutions caused by the high volume of vaccinations, JD Health will provide post-vaccination follow-up services, 24/7 children’s  online consultations, the opening of an exclusive zone on the app for JD Health’s family doctor service for children, as well as online-and-offline medical and healthcare services in accordance with the program.

“Leveraging JD Health’s previous experience on vaccination appointments and offering related services, JD Health will provide one-stop vaccination services to children. Users can consult online at any time to seek help from professional doctors for any questions in vaccine selection, pre-vaccination and post-vaccination,” said Yufang Wang, general manager of JD Health’s Consumer Medical Department.

“We believe the cooperation between JD Health and Pfizer in the field of vaccines can further help the promotion and development of ‘Internet + vaccination’ and explore a new situation of disease education and vaccination in China,” said Hua Bao, head of business optimization and innovation at Pfizer China.